- Home
- HUBS vs BAX Comparison
HUBS vs BAX Comparison
Compare HUBS & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HUBS | BAX |
|---|---|---|
| Founded | 2005 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 10.2B |
| IPO Year | 2014 | 1994 |
Fundamental Metrics
Financial Performance| Metric | HUBS | BAX |
|---|---|---|
| Price | $246.03 | $16.76 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 32 | 9 |
| Target Price | ★ $435.19 | $21.00 |
| AVG Volume (30 Days) | 1.5M | ★ 7.1M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | ★ 855.56 | N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | $375,612,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $20.46 | $1.96 |
| Revenue Next Year | $16.01 | $2.22 |
| P/E Ratio | $289.13 | ★ N/A |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $187.45 | $15.73 |
| 52 Week High | $670.54 | $32.68 |
Technical Indicators
Market Signals| Indicator | HUBS | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 57.42 | 41.61 |
| Support Level | $209.40 | $15.73 |
| Resistance Level | $250.14 | $18.97 |
| Average True Range (ATR) | 12.25 | 0.79 |
| MACD | 4.28 | -0.14 |
| Stochastic Oscillator | 81.37 | 19.54 |
Price Performance
Historical ComparisonAbout HUBS HubSpot Inc.
HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.